Carbohydrate-deficient transferrin (CDT) testing measures the proportion of transferrin in serum that lacks the normal complement of carbohydrate molecules. Elevated levels often indicate heavy alcohol consumption over a prolonged period. These measurements provide an objective indicator, unlike self-reported alcohol intake, which can be unreliable. As an example, an individual undergoing evaluation for liver disease might have this test performed to help determine the role of alcohol in their condition.
The value of understanding CDT levels resides in its capacity to assist in identifying chronic, excessive alcohol use. This has implications for medical diagnosis, legal proceedings, and workplace monitoring. Historically, recognizing problematic alcohol use relied heavily on subjective assessments. This biomarker offers a more definitive data point, contributing to more accurate and informed decision-making. Its utilization promotes better patient care, fairer legal outcomes, and safer work environments by providing a quantifiable measure of alcohol abuse.
